A recent court ruling is reshaping how hospitals should approach 340B eligibility—particularly for off-site locations. For years, many have assumed that registration in OPAIS was a prerequisite for participation. This decision challenges that framework and introduces a more nuanced, statute-driven interpretation.
In this episode, Katy Lees breaks down what the ruling actually means in practice, including the distinction between eligibility and registration, how organizations should approach defining eligibility dates, and why documentation and internal alignment are now more critical than ever. This discussion is especially relevant to compliance leaders, pharmacy teams, finance teams, and executives responsible for program oversight.
As Principal 340B Compliance Advisor at Virtue 340B, Katy brings clarity to a complex and evolving issue—helping organizations move beyond assumptions and toward defensible, well-structured decisions. Watch Now >
